baber/WOPTO huggingface dataset:
Patent NZ-223860-A (NZ)
Title: Polypeptides related to plasmodium falciparum merozoite 190kd antigen precursor. production by genetic engineering methods, vaccines and antibodies
Inventor: CERTA ULRICH
IPC: C12N1/20
Filed: 1988-03-11
Abstract: Polypeptides having an amino acid sequence which is derived from the 190 kD (1 kD = 1000 Dalton) precursor of the predominant merozoite surface antigens of the K1 isolate of P. falciparum are described. These polypeptides are capable of an immune response against various isolates of P. falciparum. Immunogenic compositions and vaccines which contain a polypeptide described above, antibodies which are produced by these polypeptides, DNA sequences which code for such a polypeptide, replicable microbial vectors which contain such a DNA sequence and microorganisms which are transformed using such a vector are additionally described. Moreover, processes for the production of the polypeptides, the immunogenic compositions, the immunogenic compositions, the microorganisms and the abovementioned antibodies and the use of these polypeptides or immunogenic compositions for the immunisation of mammals against malaria are described.
Patent NZ-239305-A (NZ)
Title: 4-benzyl-5-substituted isoxazole derivatives, preparation and herbicidal compositions thereof
Inventor: CAIN PAUL ALFRED
IPC: C07D413/06
Filed: 1991-08-08
Abstract: Compounds of the formula: <CHEM>  wherein R1 represents:     a group such as alkyl, cycloalkyl, haloalkyl, aryl or ester; R2 represents: a group such as nitro, cyano, halogen, R5, S(O)mR5, ester or alkoxy;   R5 represents alkyl or haloalkyl; R6 represents : a group such as hydrogen, hydroxy, halogen, R5, cycloalkyl, S(O)mR5 or ester; R7 represents hydrogen or R5;     and agriculturally acceptable salts thereof; the herbicidal properties of these compounds and their application to crop protection, are described.
Patent NZ-250609-A (NZ)
Title: Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
Inventor: KOGEN HIROSHI
IPC: C12R1/01
Filed: 1993-12-23
Abstract: Compounds of formula (I): <CHEM>  [wherein R<1> represents a group of formula (II) or (III): <CHEM> R<2> is alkyl, alkenyl or alkynyl; R<3> and R<4> are each hydrogen, alkyl, alkenyl or alkynyl; R<5> is hydrogen or a carboxy-protecting group; R<a> is hydrogen or a group of formula and -OR<6>; R<6>, R<6a> and R<6b> are each hydrogen, a hydroxy-protecting group, alkyl, alkanesulphonyl, halogenated alkanesulphonyl or arylsulphonyl] and their salts and esters have the ability to inhibit the synthesis of cholesterol, and can thus be used for the treatment and prophylaxis of hypercholesterolemia and of various cardiac disorders.
Patent NZ-264066-A (NZ)
Title: Chocolate or chocolate type composition with capsules of polyol enclosed within edible lipid
Inventor: BECKETT STEPHEN
IPC: A23G1/56
Filed: 1994-07-22
Abstract: A process for improving the shape retention of chocolate or chocolate type products so that they have a reduced tendency to deform at elevated temperatures which comprises mixing an encapsulated product in particulate form comprising capsules of a polyol enclosed within an edible lipid with a flowable mixture of chocolate type ingredients, the encapsulated product being added in an amount to achieve a polyol content of from 0.2 to 5% by weight based on the total amount of the resultant chocolate.
Patent NZ-273024-A (NZ)
Title: Impact injection device for once-only use has plunger and housing with interacting barb-like members
Inventor: ALLONEN HANNU
IPC: A61M5/315
Filed: 1994-09-16
Abstract: The surface (21) of the plunger and the inner wall (15) of the implant housing are equipped with interacting members (22,12) which allow the plunger to be pushed inwards into the implant housing while preventing the removal of the plunger from the implant housing. The cannula is made of plastic. The surface of the plunger is equipped with a member (22) which allows the displacement of the plunger inwards into the implant housing and that the rim or edge (12) of the implant housing distal to the cannula is shaped so that the inner cross-sectional area of the implant housing is reduced at point (16). The edge acts as a stop for the element on the surface of the plunger when the plunger is displaced outwards.
Patent NZ-284874-A (NZ)
Title: Pseudomonas chlororaphis strain production of antifungal metabolites
Inventor: GERHARDSON BERNDT
IPC: A01N63/20
Filed: 1995-04-13
Abstract: PCT No. PCT/SE95/00408 Sec. 371 Date Jan. 17, 1997 Sec. 102(e) Date Jan. 17, 1997 PCT Filed Apr. 13, 1995 PCT Pub. No. WO95/28085 PCT Pub. Date Oct. 26, 1995A pure culture of Pseudomonas chlororaphis strain NCIMB 40616 is disclosed. The strain is useful for a biocontrol composition for the control of plant fungal diseases. Further, a culture broth of the strain is disclosed to be useful wherein antipathogenically active metabolites are contained in the culture broth. In addition a method of controlling the plant fungal diseases is disclosed which is carried out by the introduction of an effective dose of the strain into a plant environment infected with fungal diseases. Also carriers and additives are admixed with the strain in order to provide for the composition. The types of pathogenic fungi which may be controlled using the method and composition are of the genera Drechslera, Microdochium, Tilletia or Ustilago.
Patent NZ-314614-A (NZ)
Title: Human epithelial colon-immortalised cell line methods for producing it and identification of mutagenic toxic or beneficial agents for the metabolism of the cell in the intestinal tract
Inventor: BLUM STEPHANIE
IPC: A61K35/38
Filed: 1997-04-16
Abstract: Immortalised human colon epithelial cell line has no tumour markers, expresses metabolic markers specific for non-immortalised human epithelial cells, expresses differentiation markers specific for non-immortalised human colon epithelial cells, and is capable of adhering to lactic acid bacterium CNCM I-1225 in vitro. Also claimed are: (1) a serum-free culture medium for culturing and immortalising human colon epithelial cells, containing inorganic salts, glucose, sodium pyruvate, amino acids, bovine serum albumin, ethanolamine, phosphoethanolamine, vitamins (vitamin C and retinoic acid), trace elements and hormones (triiodothyronine, dexamethasone, hydrocortisone, bovine pituitary extract, insulin, epithelial growth factor and transferrin), and (2) a process for immortalising human colon epithelial cells, comprising preparing a primary culture of the cells, infecting the culture with a recombinant virus, and culturing the cells in a medium as above.
Patent NZ-325752-A (NZ)
Title: Indicia selection game
Inventor: BENNETT NICHOLAS LUKE
IPC: G07F17/32
Filed: 1997-01-24
Abstract: isclosed is a slot machine providing a video display screen (11) controlled to display indicia images arranged in a matrix.  The video screen is of the touch sensitive variety, having an array of touch sensitive areas located on its display surface with one such area associated with each matrix element (40-45).  The player selects pairs of indicia (e.g. 41 and 48) by touching the screen within the area of each of the displayed indicia (i.e. within the area of the matrix element) to be selected, thereby causing the indicia to change to reveal the associated prize values.
Patent NZ-330571-A (NZ)
Title: Nitrogenous heterocyclic compounds that may contain sulphur or oxygen
Inventor: MATSUNO KENJI
IPC: C07D237/34
Filed: 1997-10-01
Abstract: The present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of PDGF receptor to hinder abnormal cell growth and cell wandering and thus are useful for the prevention or treatment of cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis. The compounds are represented by general formula (I): <CHEM>       wherein V represents an oxygen atom or a sulfur atom; W represents 1,4-piperazinediyl or 1,4-homopiperazinediyl in which carbons on the ring may be substituted by unsubstituted alkyl groups;     X represents a nitrogen atom or C-R<9>;   Y represents a nitrogen atom or C-R<8>; Z represents a nitrogen atom or C-R<7> (provided that at least one of X, Y and Z represents a nitrogen atom); R<1> represents a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alicyclic alkyl group, etc.; R<2> represents a substituted alkyl group, a substituted or unsubstituted alicyclic alkyl group, etc.; R<3>, R<4>, R<5> and R<6>, which may be the same or different, each represents a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, a nitro group, a cyano group, - OR<12>, -NR<15>R<16>, etc.;   R<7> represents a halogen atom, etc.;   R<8> has the same significance as R<7>, and R<9> represents a hydrogen atom or -COR<41>.
Patent NZ-333286-A (NZ)
Title: Method of manufacturing cheese similar to Mozzarella cheese
Inventor: CHEN CAROL M
IPC: A23C19/05
Filed: 1997-06-20
Abstract: The specification describes a method of manufacturing cheese  which has similar properties to Mozzarella filata cheeses.  The process does not require a mixing and/or molding step. The method includes the steps of : i) pre-acidifying milk; ii) ripening, at a pH of about 6.3, the milk with a mesophilic starter culture to yield cheese milk; iii) coagulating the cheese milk by adding a coagulant to yield a coagulum; iv) cutting the coagulum to yield curds and whey; v) separating the curds from the whey and washing the curds in water; and then salting, hooping, and pressing the curds in the absence of any milling, mixing, or molding. The milk is preferably ripened Lactococcus lactis subsp. Cremoris.
Patent NZ-333742-A (NZ)
Title: Gelled proteinaceous food product comprising two distinct gelled portions
Inventor: FEE IAIN
IPC: A23L17/00
Filed: 1997-07-21
Abstract: The specification describes a gelled food product  which mimics the appearance of a naturally occurring foodstuff.  The gelled food has two visually distinct portions. A core of a first heat stable gel of a first colour and a coating comprising a second heat stable gel of a second colour and a third heat stable gel of a third colour.  The second and third gels blend together where the gels meet.
Patent NZ-336071-A (NZ)
Title: Loudspeaker with resonant radiator having exciter to apply bending waves to radiator which is resiliently coupled to support
Inventor: AZIMA HENRY
IPC: H04R9/00
Filed: 1998-01-05
Abstract: A loudspeaker drive unit comprising a resonant acoustic radiator, an exciter on the radiator to apply bending wave energy to the radiator to cause it to resonate, a support for the loudspeaker drive unit, and means resiliently coupling the exciter to the support.   GnG, GGGG, GnGG and GGG, where G is guanosine and n is any nucleotide. Aptamers are administered to provide therapies for diseases which involve aberrant T-cell activation such as psoriasis, Type I (insulin-dependent) diabetes mellitus, multiple sclerosis, autoimmune uveitis, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease (Crohn's and ulcerative colitis), and septic shock and to regulate normal T-cell activation such as in allograft rejection.
Patent NZ-508491-A (NZ)
Title: Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain
Inventor: MAGNUS LESLIE
IPC: A61P43/00
Filed: 1999-06-18
Abstract: A GABA analog and decongestant combination is used  to treat  sinus headache and sinus pain.  The GABA  analog  can be either gabapentin or pregabalin.
Patent NZ-509139-A (NZ)
Title: Operating method and device for supplementary compressed air injection engine operating with mono-energy or bi-energy in two or three powering modes
Inventor: NEGRE CYRIL
IPC: F02B75/02
Filed: 1999-06-02
Abstract: The engine described includes an engine method with suction-compression chamber (1) and/or expansion-exhaust chamber (4) operating by means of reciprocating pistons with an independent and twinned compression chamber (2) - the three chambers being separated with a device controlling the stroke causing, over a long period of engine rotation, said piston (15) to stop at the upper dead centre which in that position separates the combustion chamber and the expansion-exhaust chamber, also comprising a high-pressure compressed air chamber (23) and additional systems for recuperating ambient thermal energy and additional heating, capable of operating in mono-energy air plus supplementary compressed air or in bi-energy, or with conventional fuel in internal or external combustion, or by injection of a dose of compressed air thereby producing three operating modes depending on the type of use.
Patent NZ-510259-A (NZ)
Title: Energy absorbing system for fixed roadside hazards
Inventor: ALBRITTON JAMES R
IPC: B60R19/00
Filed: 1999-08-12
Abstract: An energy absorbing system with one or more energy absorbing assemblies is provided to reduce or eliminate the severity of a collision between a moving motor vehicle and a roadside hazard. The energy absorbing system may be installed adjacent to a roadside hazard such as the end of a concrete barrier facing oncoming traffic. The energy absorbing system preferably includes at least one energy absorbing element. A sled assembly is also provided with a cutter plate such that a collision by the motor vehicle with one end of the sled assembly will result in the cutter plate tearing or ripping the energy absorbing element to dissipate energy from the motor vehicle collision. The configuration and number of energy absorbing assemblies and the configuration and number of energy absorbing elements may be varied depending upon the intended application for the resulting energy absorbing system.
Patent NZ-512104-A (NZ)
Title: Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
Inventor: DAVEY DAVID D
IPC: C07D401/14
Filed: 1999-12-03
Abstract: Compounds of formulae (I), (II) or (III) are disclosed, wherein the substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of diseases characterised by thrombotic activity.
Patent NZ-516334-A (NZ)
Title: N-pyrazole A2A receptor agonists
Inventor: ZABLOCKI JEFF A
IPC: C07H19/167
Filed: 2000-06-21
Abstract: A pyrazole derivative has the formula (I) wherein: R1 is -CH2OH or -CONR5R6; R2 and R4 are independently H, alkyl or aryl that is optionally substituted with halo, CN, CF3, OR20 or N(R20)2 with the proviso that when R2 is not hydrogen then R4 is hydrogen, and when R4 is not hydrogen then R2 is hydrogen; R3 is alkyl, halo, NO2, CF3, CN, OR20, SR20, SO2R22, N(R20)2, S(O)R22, SO2N(R20)2, SO2NR20COR22, SO2NR20CO2R22, SO2NR20CON(R20)2, NR20CO2R22, NR20CON(R20)2, NR20C(NR20)NHR22, COR20, CO2R20, N(R20)2NR20COR22, CON(R20)2, CONR20SO2R22, NR20SO2R22, SO2NR20CO2R22, OCONR20SO2R22, OC(O)R20, C(O)OCH2OC(O)R20, OCON(R20)2, -CONR7R8 or optionally substituted alkenyl, alkynyl, heterocyclyl or aryl; R5 and R6 are independently H, optionally substituted alkyl and R7, R20 and R22 are as defined in the specification. The compounds are useful as an anti-inflammatory, in adjunctive therapy with angioplasty, as a platelet aggregation inhibitor, and as an inhibitor of platelet and neutrophil activation or is useful to stress the heart and induce a coronary steal situation for the purposes of imaging the heart.
Patent NZ-524000-A (NZ)
Title: Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
Inventor: THOMPSON LAWRENCE H
IPC: A61K33/24
Filed: 2001-08-09
Abstract: Disclosed is the use of a recombinant erythropoietin produced in baby hamster kidney cells, the recombinant erythropoietin consisting of Epoetin Omega, for the manufacture of a medicament for treatment of anemia wherein said anemia is non-responsive to or produces adverse effects with treatment of a therapeutic amount of Epoetin Alfa or Beta, the medicament having a therapeutic amount of the recombinant erythropoietin selected to provide a therapeutic benefit within a treatment period.
Patent NZ-526707-A (NZ)
Title: Use of SMARC nucleic acid and polypeptide expression analysis for the diagnosis and prognosis of prostate cancer
Inventor: GILLIS KIMBERLY A
IPC: C12Q1/6886
Filed: 2001-11-28
Abstract: Described are compositions, kits, and methods for detecting, characterising, preventing, and treating prostate cancer. SWI/SNF-related matrix-associated actin-dependent regulator of chromatin (SMARC) markers are provided, wherein changes in the levels of expression of one or more of the SMARC markers is correlated with the presence of prostate cancer.
Patent NZ-532846-A (NZ)
Title: Tooth-cleaning paper combined with dental floss
Inventor: LEE JONG-SOO
IPC: A61C15/04
Filed: 2002-11-11
Abstract: Disclosed is a tooth-cleaning paper combined with a dental floss, characterized by combining the dental floss functioning to remove inter-dental debris to the tooth-cleaning paper for use in scrubbing food debris stuck onto the teeth. Thereby, food debris stuck onto or held between the teeth is easily removed while the mouth is hidden with the cleaning paper, thus not giving other persons an unpleasant feeling. Further, the dental floss which conventionally suffers from difficult storage and excessive use due to slipping thereof is easily and economically used in state combined to the cleaning paper.
Patent NZ-532997-A (NZ)
Title: Architecture for connecting a remote client to a local client desktop
Inventor: BILLHARZ ALAN M
IPC: G06F21/33
Filed: 2004-05-18
Abstract: A system that facilitates remotely connecting an external computer outside of a router and/or firewall and/or protected intranet to an internal computer that is part of the intranet comprises a request component and a connection component. The request component receives a request to remotely connect to at least one internal computer of a plurality of available computers that are part of the intranet. The connection component in response to an authentication of the request creates a thread to manage a network connection between a listening socket port of a router and/or firewall and a port of the at least one computer designated at least in part for network connections. The connection component dynamically listening on the ports and passes a port value back to the external computer in the form of a URL.
Patent NZ-535903-A (NZ)
Title: Copper silicate in topical compositions to prevent and treat infection with microbial nail pathogens
Inventor: SHEEN RONALD JAMES
IPC: A61P31/04
Filed: 2003-04-17
Abstract: The use of an effective amount of copper silicate by topical administering to the nail to treating or prevent a microbial disease, such as onychomycosis, of a subject's nail is described.
Patent NZ-540607-A (NZ)
Title: Methods for inhibiting cancer and scar formation
Inventor: HAMDI HAMDI K
Filed: 2003-12-04
Abstract: Disclosed is the use of a compound of formula (I), wherein the substituents are as defined in the specification, in the manufacture of a medicament for disrupting and preventing the reorganization of the cytoskeleton whereby an animal cell assumes a spherical configuration and is unable to divide, move, or invade, or whereby an animal cell becomes globular.
Patent NZ-541192-A (NZ)
Title: Plasmid-free clone of E. coli strain DSM 6601 and method for its creation using sacB and two resistance genes introduced into the pMut1 and pMut2 plasmids
Inventor: HACKER JORG
IPC: C12N15/70
Filed: 2004-06-25
Abstract: Disclosed is a plasmid free clone of the E. coli strain DSM 6601, and a method of preparing it. The method involves the introduction of a resistance gene and the sacB gene into each of the plasmids pMut1 and pMut2, which are the plasmids that are usually found in this strain. The modified plasmids are introduced into the bacteria under conditions such that the naturally occurring plasmids are replaced by the modified ones. The bacteria are grown under conditions selecting for the particular resistance used in the plasmids, and then are grown under conditions that select against sacB. Preferably each plasmid has a different antibiotic resistance, and more preferably the pMut1 plasmid has a tetracycline resistance cassette, and pMut2 plasmid has a kanamycin resistance cassette, with the elimination of each plasmid taking place in two separate steps.
Patent NZ-544244-A (NZ)
Title: Dual NK1/NK3 antagonists for treating schizophrenia
Inventor: HOFFMANN TORSTEN
IPC: C07D417/04
Filed: 2004-06-25
Abstract: Disclosed are compounds of formula I, wherein the substituents are as defined in the specification, processes for their preparation and their use in the manufacture of a medicament for the treatment of schizophrenia.
Patent NZ-546245-A (NZ)
Title: An apparatus and method for allocating a prize
Inventor: JOMAA ALI
IPC: A63F13/12
Filed: 2004-10-21
Abstract: A method of allocating a prize using a gaming apparatus is disclosed. The gaming apparatus includes a primary controller (1) for determining the award of a prize, and an auxiliary controller (2) that is capable of communication with the primary controller (1). The auxiliary controller (2) is further capable of communication with one or more gaming terminals (4). The method includes the steps of (a) receipt by the auxiliary controller (2) of data from one or more of the gaming terminals (4) where the data includes at least one gaming terminal identifier and associated gaming terminal accumulated amount, (b) storage of the data in a memory accessible to the auxiliary controller (2), (c) being responsive to the gaming terminal (4) accumulated amounts for deriving a total contributory amount, (d) communication from the auxiliary controller (2) to the primary controller (1) of the total contributory amount, (e) determination by the primary controller (1) of whether or not to award a prize based upon the total contributory amount, (f) where the determination is to award a prize, communication from the primary controller (1) to the auxiliary controller (2) of data associated with the determination, and (g) analysis by the auxiliary controller (2) of the data associated with the determination and the data stored in the memory to determine to which of the gaming terminals (4) prize is to be allocated.
Patent NZ-547022-A (NZ)
Title: Footwear
Inventor: KING JUSTIN DOUGLAS
IPC: A63B69/00
Filed: 2004-10-13
Abstract: Footwear, such as sandals (10) (of the type also known as "thongs" or "jandals") has soles (11) with shapes replicating surfboard designs, such as 'pintail', 'swallow tail' and 'square tail' and may incorporate leg ropes, stringers, hips or flyers, raised heel grips and ornamentation of one, two or three fins. The raised heel grips provide support and/or grip to a wearer's heel. The footwear may also be used as a hand surfer for body surfers and incorporate a wrist strap for releasable attachment to a wearer's wrist.
Patent NZ-553756-A (NZ)
Title: Ergonomic and adjustable respiratory mask assembly
Inventor: GING ANTHONY
IPC: A61M16/08
Filed: 2003-04-17
Abstract: A nasal mask assembly for nasal CPAP therapy, comprising: a mask frame; a silicone nasal seal which can be repeatedly detached from and reattached to the frame; an elbow rotatably coupled to the frame and adapted to connect to a gas delivery tube; and a headgear assembly (80) to secure the frame and nasal seal to a patient's head. The headgear assembly includes a pair of relatively flexible, Y-shaped straps (84) having a relatively soft fabric and foam material construction, and a stiffening support structure (92) made of a relatively rigid material compared to the strap material. The stiffening support structure is stitched to an outside surface of at least a front portion of the straps. The stiffening support structure is narrower than the strap portion.